Leukemia Clinical Trials in Salt Lake City

Showing 681-685 of 685 trials

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT00129948

This is a phase 2, single-arm, open-label, multi-center study to establish the safety and efficacy of Troxatyl™ (troxacitabine) administered as a continuous infusion for 5 days to subjects with AML.

Leukemia, Myeloid, Acute

SGX Pharmaceuticals, Inc.211 participantsStarted Jul 2005

La Jolla, California, United States • Los Angeles, California, United States • San Diego, California, United States +17 more locations

UNKNOWNPHASE467 miles

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

NCT00131313

This research study measures the safety and efficacy of the combination of three drugs that are approved, Nipent, Rituxan and Cytoxan in the treatment of Chronic Lymphocytic Leukemia (CLL). These drugs are being given together for investigational purposes as the specific combination of these three drugs has not been approved for treatment of CLL by the FDA.

Chronic Lymphocytic Leukemia

East Valley Hematology and Oncology Medical Group180 participantsStarted Jan 2003

Muscle Shoals, Alabama, United States • Burbank, California, United States • Concord, California, United States +49 more locations

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Leukemia Trials in Other Cities

Amonafide in Combination With Cytarabine in Secondary AML

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Other Conditions in Salt Lake City